Search Results - H. Cen
- Showing 1 - 2 results of 2
-
1
S215: GEMSTONE-201: PRE-PLANNED PRIMARY ANALYSIS OF A MULTICENTER, SINGLE-ARM, PHASE 2 STUDY OF SUGEMALIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY EXTRANODAL NATURAL KILLER/T CELL... by H. Huang, R. Tao, Y. Yang, H. Cen, H. Zhou, Y. Guo, L Zou, J. Cao, Y. Huang, J. Jin, L. Zhang, H. Yang, X. Xing, H. Zhang, Y. Liu, K. Ding, X. Zhu, T. Fang, H. Dai, Q. Qi, J. Yang
Published in HemaSphere (2022-06-01)Get full text
Article -
2
P1119: THE ORAL PI3KΔ INHIBITOR LINPERLISIB FOR THE TREATMENT OF RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: A SINGLE-ARM MULTICENTER PHASE 2 CLINICAL TRIAL by T. wang, X. sun, L. qiu, H. su, J. cao, Z. li, Y. song, L. zhang, S. yi, L. qiu, J. zhou, H. wu, W. zhang, J. li, K. zhou, H. zhou, Y. yang, Z. li, H. cen, Z. cai, Z. zhang, W. fu, J. jin, F. li, W. wu, X. gu, W. zhu, L. liu, Z. li
Published in HemaSphere (2022-06-01)Get full text
Article
